AI Collaboration Between Sanofi and Healx Will Target Novel Rare Diseases Indications
Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.
Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible to millions more individuals.
Zigzagging light bent by perfectly aligned galaxies could improve estimates of Hubble constant
Canada ordered ByteDance Ltd. to wind up its subsidiary TikTok Technology Canada, Inc. — though the move will not stop Canadians from using the popular…
With the assistance of China’s Zhurong rover, scientists have gathered fresh evidence that Mars was home to an ocean billions of years ago – a…
Government and industry want to jump-start the conversation around “human-centric cybersecurity” to boost the usability and effectiveness of security products and services.
Introduction A central question in the discussion of large language models (LLMs) concerns the extent to which they memorize their training data versus how they…
Four-legged robots, also known as quadrupedal robots, have advantageous characteristics, including the ability to rapidly walk on challenging terrains and keep a low center of…
Immune-cell therapy shrank children’s brain tumors, restored neurologic function and—for one participant—erased all detectable traces of a brain cancer.
Researchers at ETH Zurich have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the…
Six months after backlash, AI company fulfills pledge to make AlphaFold3’s full computer model available for noncommercial use